Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Bullboard Posts
Comment by 2b7f6fabon Jul 27, 2017 6:36pm
138 Views
Post# 26519085

RE:RE:RE:Management: dont sell part to Frost

RE:RE:RE:Management: dont sell part to FrostVestor- what you describe below regarding big pharma is imo exactly where Dr Frost is right now.   RW owns 6 million shares out of 166 million fully diluted.  I suspect Dr Frost owns a lot more than RW when taking into consideration the warrants I suspect he owns.  Frost could make a bid for the company right now.  Of course he doesn't have control and big pharma lots more fire power.  But Frost already knows what we have here and big pharma is only now looking.

vestor111 wrote:
If a large pharma sweeps in and files beneficial ownership (ie above 10%), that doesn't stop them from continuing to buy possibly making a bidding war a non-event.   A bidding war might prove out but at these prices, the company could be swept up without much in the way of bidding.  

In a deal with Frost, Frost would have to be fairly open and strike a win-win deal.   And I doubt Roger would settle for less and time would be on Roger's side.  

If Frost fails at licensing before any potential take-out, he may lose a significant asset to the in-roads he has made his Uro-oncology market and Roger could lose a significant partner-ally who could advise him and the board on how to tread these waters - waters Roger's team has very little knowledge of. 

Frost's relationship could keep the company public long enough to prove-in more of what they have to offer thus potentially achieving fairer valuations for what they have achieved.

My primary concern it to achieve maximum value and if a bidding war erupts in the near term, it is very doubt we would achieve a price anywhere the company is really worth (assuming all continues as it appears).    This would be worse if a big player swept the field early by locking up enough shares to thwart other rivals.  This looms as a real possibility I believe thus my interest in a win-win realtionship with Frost that allows TLT to build its story and valuation befoire the bidding begins and more understand what they have to offer.


Bullboard Posts